Optiscan Imaging (ASX:OIL) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:OIL Optiscan Imaging Ltd ASX:OIL
22 GF Score
Price A$0.16
GF Value A$0.04
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Optiscan Imaging Short-term investments?

Short-term investments only applies to insurance companies.

ASX:OIL
22GF Score
Optiscan Imaging Ltd ASX:OIL
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Optiscan Imaging (ASX:OIL) Overvalued in 2026?

Based on GuruFocus' analysis, Optiscan Imaging stock appears to be overvalued. The current stock price of A$0.16 is trading 287.5% above its estimated GF Value™ of A$0.04. GuruFocus considers Optiscan Imaging to be Significantly Overvalued.

Key valuation signals for ASX:OIL:

  • Short-term investments:
  • GF Value™: A$0.04 vs. price of A$0.16 (287.5% above fair value)
  • GF Score™: 22/100 with 6 warning signs

No single metric tells the full story. See the ASX:OIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Optiscan Imaging Business Description

Address 16 Miles Street, Mulgrave, Melbourne, VIC, AUS, 3170
Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.
22GF Score

Get the complete analysis for ASX:OIL

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.16
Price
A$0.04
GF Value